April 08, 2026 a 09:00 am
CNC: Analysts Ratings - Centene Corporation
Centene Corporation, a leading healthcare enterprise, is subject to varied analyst opinions. Recently, the stock has shown substantial stability with a predominant trend towards 'Hold' ratings. This indicates a neutral sentiment among analysts with cautious optimism or hesitation for aggressive investment actions.
Historical Stock Grades
Analyzing historical ratings reveals a distinct neutrality in analysts' sentiments towards CNC, with a strong preference for 'Hold' recommendations. The following table displays the distribution of ratings as of April 2026:
| Rating Type | Number of Ratings | Score Bar |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 3 | |
| Hold | 13 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
- The past year noted a gradual decline in 'Strong Buy' ratings, replaced by a steady increase in 'Hold' ratings.
- Overall, the sentiment transitioned from optimism to a more measured and cautious stance.
- The shift in sentiment suggests uncertainty or perceived stabilization in the company's potential for substantial growth.
- The marked increase in the 'Hold' ratings indicates analysts are advising investors to maintain their positions without aggressive buying or selling.
Percentage Trends
- The percentage of 'Hold' ratings has notably increased, showing a significant sentiment shift over 12 months from strong bullishness to neutrality.
- In recent months, the consistency of 'Hold' recommendations points to a consolidating opinion among analysts.
- 'Strong Buy' recommendations have decreased by 50% over the last year, reflecting reduced optimism.
- Analysts are showcasing more restraint, transitioning from buy-oriented advice to neutral stances, echoing broader market caution.
Latest Analyst Recommendations
The latest batch of recommendations indicates a stable continuation of existing opinions, with no significant upgrades or downgrades.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-19 | Neutral | Neutral | JP Morgan |
| 2026-03-11 | Neutral | Neutral | Mizuho |
| 2026-03-04 | Equal Weight | Equal Weight | Morgan Stanley |
| 2026-02-18 | Equal Weight | Equal Weight | Wells Fargo |
| 2026-02-09 | Neutral | Neutral | Cantor Fitzgerald |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-05 | Overweight | Equal Weight | Barclays |
| 2025-07-28 | Neutral | Overweight | Cantor Fitzgerald |
| 2025-07-23 | Equal Weight | Overweight | Wells Fargo |
| 2025-07-21 | Hold | Buy | TD Cowen |
| 2025-07-16 | Underperform | Neutral | B of A Securities |
Interpretation
The overarching sentiment suggests a marketwide reassessment of Centene's growth potential. Analysts' reluctance to heavily endorse substantial buying reflects an environment of careful observation. The prevalence of 'Hold' ratings underscores a perception of stabilizing performance with balanced risk and reward expectations. Current trends hint at a nuanced stance, with no strong directional sentiment and rooted mainly in neutrality. While some opinions have shifted toward cautious optimism or a reduction in enthusiasm, overall, the outlook remains steady.
Conclusion
Centene Corporation's current market stance is characterized by stability but cautious optimism among analysts. The predominant 'Hold' ratings signify a balanced level of confidence in the stock's future performance while acknowledging potential risks. Recent trends highlight a significant decrease in aggressive buying signals, implying a reevaluation of the company's growth trajectory. Overall, the sentiment indicates restrained confidence, prompted by broader market conditions and internal company factors. Investors are advised to maintain positions and remain observant of emerging trends that can shift sentiment strongly in either direction.